Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Accurso

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Chest|May 19, 2012
Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosaFelix Ratjen, Lisa Saiman, Nicole Mayer-Hamblett, et al.
Critical Care Medicine|June 27, 2012
Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13Max Wohlauer, Ernest E Moore, Christopher C Silliman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 21, 2017
Biomarkers for cystic fibrosis drug developmentMarianne S Muhlebach, J P Clancy, Sonya L Heltshe, et al.
Diabetes|February 20, 2014
Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization studyDavid Soave, Melissa R Miller, Katherine Keenan, et al.
Plos One|February 7, 2015
Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosisThomas Flass, Suhong Tong, Daniel N Frank, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 6, 2008
Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics ProgramsRobert E Gerszten, Frank Accurso, Gordon R Bernard, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2018
Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized TrialNicole Mayer-Hamblett, George Retsch-Bogart, Margaret Kloster, et al.
The Journal of Pediatrics|January 29, 2017
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis FoundationPhilip M Farrell, Terry B White, Clement L Ren, et al.
Chest|May 18, 2010
An international randomized multicenter comparison of nasal potential difference techniquesGeorge M Solomon, Michael W Konstan, Michael Wilschanski, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2002
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosisRonald L Gibson, Julia Emerson, Sharon McNamara, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Chest|May 19, 2012
Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosaFelix Ratjen, Lisa Saiman, Nicole Mayer-Hamblett, et al.
Critical Care Medicine|June 27, 2012
Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13Max Wohlauer, Ernest E Moore, Christopher C Silliman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 21, 2017
Biomarkers for cystic fibrosis drug developmentMarianne S Muhlebach, J P Clancy, Sonya L Heltshe, et al.
Diabetes|February 20, 2014
Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization studyDavid Soave, Melissa R Miller, Katherine Keenan, et al.
Plos One|February 7, 2015
Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosisThomas Flass, Suhong Tong, Daniel N Frank, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 6, 2008
Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics ProgramsRobert E Gerszten, Frank Accurso, Gordon R Bernard, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2018
Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized TrialNicole Mayer-Hamblett, George Retsch-Bogart, Margaret Kloster, et al.
The Journal of Pediatrics|January 29, 2017
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis FoundationPhilip M Farrell, Terry B White, Clement L Ren, et al.
Chest|May 18, 2010
An international randomized multicenter comparison of nasal potential difference techniquesGeorge M Solomon, Michael W Konstan, Michael Wilschanski, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2002
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosisRonald L Gibson, Julia Emerson, Sharon McNamara, et al.
Pageof 3